GE HealthCare CTO has 1,502 shares withheld

GE HealthCare’s chief technology officer had shares withheld to cover taxes on RSU vesting, and this was not an open-market sale.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that Chief Technology Officer Taha Kass-Hout had 1,502 shares of common stock withheld on September 3, 2026 to satisfy tax withholding obligations upon the vesting of restricted stock units. This tax-related disposition left him holding 88,467 shares of GE HealthCare common stock directly.

Insider Trade Summary

Tax Withholding: 1,502 shares

Tax Withholding 1 txn

Insider Kass-Hout Taha

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.01 per share F1	1,502	$70.56	$106K

Holdings After Transaction: Common Stock, par value $0.01 per share — 88,467 shares (Direct)

Footnotes (1)

1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Key Figures

Shares withheld for taxes: 1,502 shares Reported value per share: $70.56 per share Shares held after transaction: 88,467 shares

3 metrics

Shares withheld for taxes 1,502 shares Common stock withheld on September 3, 2026 to satisfy tax withholding obligations

Reported value per share $70.56 per share Applied to 1,502 withheld GE HealthCare common shares

Shares held after transaction 88,467 shares Direct ownership of GE HealthCare common stock following the September 3, 2026 transaction

Key Terms

restricted stock units, tax withholding obligations, Common Stock, Rule 10b5-1

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting"

Common Stock financial

"GE HealthCare Technologies Inc. common stock to satisfy tax withholding"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"no Rule 10b5-1 trading plan was affirmed for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did GEHC’s Chief Technology Officer report?

Taha Kass-Hout reported a withholding of 1,502 GEHC shares of common stock on September 3, 2026 to cover tax withholding obligations arising from the vesting of restricted stock units.

How many GEHC shares were involved in the tax withholding transaction?

The transaction involved 1,502 shares of GE HealthCare Technologies Inc. common stock, withheld to satisfy tax withholding obligations related to restricted stock unit vesting.

What was the reported price per GEHC share in the Form 4?

The Form 4 reports a value of $70.56 per share for the 1,502 GE HealthCare common shares withheld to satisfy tax withholding obligations.

How many GEHC shares does Taha Kass-Hout own after this transaction?

After the tax withholding transaction, Taha Kass-Hout directly holds 88,467 shares of GE HealthCare Technologies Inc. common stock.

Was the GEHC insider transaction an open-market sale?

No. The filing describes the transaction as a payment of tax liability by delivering or withholding securities in connection with restricted stock unit vesting, not as an open-market sale.

Was the GEHC Form 4 transaction under a Rule 10b5-1 trading plan?

No. The Form 4 data indicates no Rule 10b5-1 trading plan was affirmed for this transaction, meaning it is not reported as made under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:43 PM Accepted by SEC EDGAR 09/04/2026 - 04:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kass-Hout Taha

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/03/2026		F		1,502(1)	D	$70.56	88,467	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)